MYELOID NEOPLASMS
Clara D. Bloomfield, MD
The Ohio State University Comprehensive Cancer Center
Conducted groundbreaking work in chromosome changes, including the Philadelphia chromosome
Acceptance Speech
- Clara D. Bloomfield, MD, is a Distinguished University Professor, the William
G. Pace III Endowed Chair in Cancer Research, and cancer scholar and senior
advisor at The Ohio State University Comprehensive Cancer Center. Her work
and accomplishments include:
- Early research focused on the study of chromosome abnormalities in cancers of the hematopoietic system
- Key contributor in discovering the Philadelphia chromosome in patients with acute lymphoblastic leukemia (ALL), and in describing the rearrangement of chromosome 16q22 in acute myeloid leukemia (AML)
- Recent research focusing on molecular changes that occur in adults with AML
- Among the first to prove that elderly patients with AML, long believed to be fatal, could be cured through chemotherapy
- Demonstrated that patients with certain types of leukemia required stem cell transplantation for cure, while others could be treated successfully without undergoing such intense intervention
- Assumed the directorship of The Ohio State University Comprehensive Cancer Center in 1997, the third woman to lead a National Cancer Institute—designated center
- Advanced the role of women in medicine through her active mentorship, by serving as a role model, and through enhancing university policy guidelines on equal employment and other issues for women faculty
